35Pharma

35Pharma is a clinical-stage biopharmaceutical company specializing in TGF-beta superfamily therapeutics for the treatment of Cardiometabolic Disease and Obesity.

Overview Structured Data Issues Contributors

35pharma.com

Is a

Organization

Company

Company attributes

Industry

Health technology

Biotechnology

Pharmaceutical industry

Location

B2X

CEO

Number of Employees (Ranges)

11 – 50

Email Address

info@35pharma.com

Investors

‌

Columbia Threadneedle Investments

‌

Frazier Life Sciences

Logos Capital

Total Funding Amount (USD)

53,000,000

Latest Funding Round Date

November 26, 2024

Latest Funding Type

Series C

Other attributes

Latest Funding Round Amount (USD)

53,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like 35Pharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.